Rockwell Medical (RMTI) Net Income towards Common Stockholders (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Net Income towards Common Stockholders came in at -$1.3 million in Q2 2026, up 16.32% on a YoY basis from -$1.1 million in Q2 2025, and up 24.52% quarter-over-quarter from -$1.7 million in Q1 2026.
Powered by 
Analysis
Rockwell Medical (RMTI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 16.32% year-over-year to -$1.3 million; the trailing twelve-month figure through Jun 2026 stood at -$5.5 million (down 144.47% YoY), and the FY2025 full-year result was -$5.6 million, down 907.4% from the prior year.
- Net Income towards Common Stockholders improved to -$1.3 million in Q2 2026 per RMTI's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $1.7 million in Q3 2024 and bottomed at -$7.2 million in Q1 2022.
- Historically, Net Income towards Common Stockholders has averaged -$2.0 million across 5 years, with a median of -$1.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders jumped 179.54% in 2024, then slumped 632.88% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$2.4 million in 2022, then jumped by 31.71% to -$1.6 million in 2023, then surged by 51.7% to -$779000.0 in 2024, then rose by 17.84% to -$640000.0 in 2025, then tumbled by 103.44% to -$1.3 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.3 million, -$1.7 million, and -$640000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 49.48 Bn | 48.62 Bn | 2.32 Bn | 378.00 Mn |
| 2 | Medline | 29.24 Bn | 26.56 Bn | 2.22 Bn | 139.00 Mn |
| 3 | West Pharmaceutical Services | 23.94 Bn | 23.51 Bn | 329.20 Mn | 147.90 Mn |
| 4 | Baxter International | 12.66 Bn | 10.51 Bn | 1.03 Bn | 126.00 Mn |
| 5 | Stevanato Group S.p.A | 5.51 Bn | 5.40 Bn | 100.91 Mn | 26.69 Mn |
| 6 | Acme United | 233.67 Mn | 228.63 Mn | 26.69 Mn | 5.05 Mn |
| 7 | Rockwell Medical | 31.87 Mn | 7.07 Mn | 3.24 Mn | -1.30 Mn |
| 8 | Retractable Technologies | 21.39 Mn | -18.48 Mn | 190,852.00 | 2.77 Mn |
| 9 | United Health Products | 9.09 Mn | 9.06 Mn | - | -217,306.00 |
| 10 | Cuprina Holdings (Cayman) | 7.45 Mn | 4.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.30 Mn |
| Mar 31, 2026 | -1.73 Mn |
| Dec 31, 2025 | -640,000.00 |
| Sep 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.56 Mn |
| Mar 31, 2025 | -1.57 Mn |
| Dec 31, 2024 | -779,000.00 |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.61 Mn |
| Sep 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -3.31 Mn |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -2.36 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.97 Mn |
| Mar 31, 2022 | -7.17 Mn |
| Dec 31, 2021 | -8.94 Mn |
| Sep 30, 2021 | -7.58 Mn |